Compare ARK Genomic Revolution ETF (ARKG) vs Occidental Petroleum Corporation (OXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Occidental Petroleum Corporation — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Occidental Petroleum Corporation trades at $53.98 (market cap $52.61B). The key difference: Occidental Petroleum Corporation pays a 1.97% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Occidental Petroleum Corporation nearer its low. Which is the better fit depends on your goals.
| ARKG | OXY | |
|---|---|---|
Sector | Sector/Thematic | Energy |
52-Week High | $43.57 | $66.24 |
52-Week Low | $23.09 | $38.92 |
Market Cap | — | $52.61B |
Enterprise Value | — | $73.69B |
Dividend Yield | — | 1.97% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Occidental Petroleum (OXY) trades at $52.89, up 1.13% today, with a bullish technical signal from moving averages and strong earnings beats in recent quarters. The company shows robust profitability with a 22.42% net income margin and 14.04% ROE, though revenue has declined from $36.6B in 2022 to $21.6B in 2025. Recent news highlights rising oil prices from Middle East tensions boosting realized prices, while debt reduction and CrownRock asset integration remain focal points.
Outlook is mixed: analyst consensus is bullish with a $65.86 price target (50% buy ratings), but high P/E of 71.47 suggests premium valuation. Key opportunities include oil price leverage and carbon capture initiatives; risks involve oil volatility, debt levels, and execution under new CEO Richard Jackson. Cash flow trends show variability, with 2026 projecting positive net cash flow of $1.2B.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Occidental Petroleum Corporation
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →
